Basit öğe kaydını göster

dc.contributor.authorEmre, Sevinc
dc.contributor.authorIsbir, TURGAY
dc.contributor.authorBilge, Ilmay
dc.contributor.authorErgen, Arzu
dc.contributor.authorYilmaz, Alev
dc.contributor.authorSirin, Aydan
dc.contributor.authorSucu, Aysegul
dc.date.accessioned2021-03-03T08:58:01Z
dc.date.available2021-03-03T08:58:01Z
dc.date.issued2011
dc.identifier.citationEmre S., Sirin A., Ergen A., Bilge I., Sucu A., Yilmaz A., Isbir T., "Methylenetetrahydrofolate reductase C677T polymorphism in patients with Henoch-Schonlein purpura", PEDIATRICS INTERNATIONAL, cilt.53, sa.3, ss.358-362, 2011
dc.identifier.issn1328-8067
dc.identifier.otherav_1a72bd15-e21a-417d-b6d6-4bac0b041318
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/23054
dc.identifier.urihttps://doi.org/10.1111/j.1442-200x.2010.03247.x
dc.description.abstractAim: Associations between several vascular diseases such as Kawasaki disease, venous and arterial thromboembolism, cardiovascular disease, diabetic nephropathy, focal segmental glomerulosclerosis and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism have been reported. This is a clinical study designed to investigate the possible effects of MTHFR C677T polymorphism on the development of Henoch-Schonlein purpura (HSP).
dc.language.isoeng
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectPEDİATRİ
dc.titleMethylenetetrahydrofolate reductase C677T polymorphism in patients with Henoch-Schonlein purpura
dc.typeMakale
dc.relation.journalPEDIATRICS INTERNATIONAL
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume53
dc.identifier.issue3
dc.identifier.startpage358
dc.identifier.endpage362
dc.contributor.firstauthorID8078


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster